Biolase, Inc. (BIOL) News

Biolase, Inc. (BIOL): $0.67

-0.02 (-2.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BIOL News Items

BIOL News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BIOL News Highlights

  • BIOL's 30 day story count now stands at 6.
  • Over the past 18 days, the trend for BIOL's stories per day has been choppy and unclear. It has oscillated between 1 and 3.

Latest BIOL News From Around the Web

Below are the latest news stories about Biolase Inc that investors may wish to consider to help them evaluate BIOL as an investment opportunity.

BIOLASE and Healthy Smiles for Kids of Orange County (Healthy Smiles) Invite California Dental Community to Awareness Reception on Sept. 24

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and Healthy Smiles for Kids of Orange County (Healthy Smiles) are inviting dental professionals in the Orange County area to an awareness reception around the shared mission to improve the oral health of children in the community.

Yahoo | September 14, 2021

7 of the Best Penny Stocks for Any Portfolio

As the global economy recovers in fits and starts, one way to play the long-term expansion in global markets is with solid penny stocks.

Louis Navellier and the InvestorPlace Research Staff on InvestorPlace | September 13, 2021

BIOLASE Schedule Of Investor Conferences For September 2021

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its schedule of investor conferences for September 2021:

Yahoo | September 8, 2021

BIOLASE Announces Clinical Advisory Partnership with Leading Endodontist Dr. L. Stephen Buchanan

Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan that will help expand laser adoption and increase hands-on training programs with one of the global leaders in endodontics.

Yahoo | August 31, 2021

The 6 Best Penny Stocks to Buy for September

Investing in penny stocks can be an intriguing numbers game.

Chris Markoch on InvestorPlace | August 30, 2021

Global Dental Veneers Market Report Forecast to 2021-2027 |key players are Colgate-Plmolive, Dentsply International, Zimmer, PHILIPS, DenMat, Ultradent Products, Lion, Henkel, Trident, Sirona Dental Systems, Align Technology, Biolase, Planmeca Oy, P&G, Un

Global Dental Veneers Market is driven by rising instances of dental embeds and expanding number of patients with corrective dentistry and rise dental the travel industry in developing business sector. Ascend in discretionary cashflow and expansion in speculations are probably

OpenPR | August 27, 2021

Can BIOLASE (BIOL) Stock Continue to Grow Earnings?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider BIOLASE (BIOL).

Yahoo | August 19, 2021

Gauging Biolase Inc’s Risk Factors

Shares of Biolase Inc. (BIOL) are up about 22% since its consensus-beating Q2 results on August 12. Biolase’s dental laser systems enable various minimally invasive dental procedures. It also provides consumable products and accessories for its systems. Let’s take a look at the latest financial performance of the company and see what has changed in its key risk factors that investors should know. Biolase’s net Q2 revenue jumped 211% year-over-year to $9.1 million as more dental practices opened amid easing of pandemic restrictions, along with a robust addition of new customers in the U.S.

Kailas Salunkhe on TipRanks | August 17, 2021

BIOLASE Expands Core Capabilities As It Appoints Three New Board Members With Significant Dental Experience

Demonstrating a deep commitment to expanding the core capabilities and diversity of its Board of Directors, BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has appointed three new board members to its Board of Directors (the "Board"), effective immediately. Drs. Kathleen T. O'Loughlin, Carol Gomez Summerhays, and Martha Somerman join a Board that has been instrumental in establishing and implementing the Company's business plan, which has demonstrated signifi

Yahoo | August 16, 2021

Health Check: How Prudently Does BIOLASE (NASDAQ:BIOL) Use Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Yahoo | August 14, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6726 seconds.